Compare JPMorgan Chase & Co (JPM) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Chase & Co vs uniQure N.V. Ordinary Shares — how do they compare? JPMorgan Chase & Co trades at $339.7 (market cap $890.37B), while uniQure N.V. Ordinary Shares trades at $21.53 (market cap $1.45B). The key difference: JPMorgan Chase & Co is far larger — about 614× uniQure N.V. Ordinary Shares's market cap, and JPMorgan Chase & Co pays a 1.97% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Chase & Co for 127 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| JPM | QURE | |
|---|---|---|
Market Cap | $890.37B | $1.45B |
Volume | 10,236,412 | 3,323,243 |
Sector | Financials | Health |
52-Week High | $365.18 | $70.59 |
52-Week Low | $282.84 | $9.03 |
Typical Hold Time | 127 Days | 0 Days |
Enterprise Value | $1.40T | $707.46M |
Dividend Yield | 1.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase (JPM) trades at $331.43, down 0.86% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 14.06, net income margin of 32.48%, and ROE of 17.91%. Recent earnings beat expectations in Q1 and Q2 2026 but missed in Q3. Revenue has grown from $128.6B in 2022 to $181.85B in 2025, with net income reaching $57.05B. Analyst consensus is a Moderate Buy with a $373.36 price target, indicating 12.6% upside. CEO Jamie Dimon's recent shareholder letter highlighted economic risks, including geopolitical tensions and inflation.
JPMorgan's outlook is supported by solid profitability and analyst optimism, but risks include volatile cash flows, rising debt levels, and macroeconomic headwinds. The stock's current valuation offers potential upside relative to consensus targets, though investors should monitor earnings consistency and management's guidance amid ongoing market uncertainties.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
